IHS Chemical Week

BASF acquires 97.7% shares of Pronova BioPharma

11:29 AM MST | January 21, 2013

BASF says that about 97.7% of all shares of Pronova BioPharma (Lysaker, Norway), a pioneer in omega-3 fatty acid research and manufacturing, have been tendered to BASF during the offer period. BASF, in November 2012, reached an agreement with Pronova to make a recommended voluntary public takeover offer to Pronova’s shareholders and offered to pay 12.50 Norwegian kroner in cash for each Pronova share. Earlier this month, BASF increased its offer price to NK13.50/share. The extended offer period for BASF’s voluntary cash offer to Pronova shareholders ended on...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.

 

 

If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa